Study of a real-time monitoring system for intrafraction patient motion in stereotactic body radiation therapy (Lung and Liver cancers)

Study of a real-time monitoring system for intrafraction patient motion in stereotactic body radiation therapy (Lung and Liver cancers) - Study of the effectiveness for the real-time intrafraction patient motion monitoring system in stereotactic body radiation therapy

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009047

Enrollment

Registered

2012-10-05

Start date

2012-10-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung and Liver cancers

Interventions

The real-time intrafraction patient motion monitoring system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ECOG PS is equal and less than 2 some small tumors in the lungs or liver treated with stereotactic body radiotherapy

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Deviation of the landmarks in X-ray radiographs from the beginning to the end of the treatment	—

Secondary

Measure	Time frame
Measurement value of the real-time monitoring system for patient intrafraction motion	—

Countries

Japan

Contacts

Public ContactYukihiro Uchida

Tokyo Radiation Oncology Clinic radiology

uchida.troc@gmail.com03-3529-5420

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026